US2019218611A1PendingUtilityA1
Methods for variant detection
Est. expiryNov 25, 2035(~9.3 yrs left)· nominal 20-yr term from priority
C12Q 1/6858C12Y 301/26004C12Q 1/6876C12Q 2600/156C12N 2310/20C12Q 1/6853C12N 15/11C12N 9/22C12Y 207/07007C12Y 301/00C07K 2319/21C12Q 2535/125C12Q 2525/186C12Q 2525/185C12Q 2525/161C12Q 2525/155C12Q 2525/121C12Q 2521/327C12N 9/1252G16B 30/00G16B 20/20C12Q 1/6827
76
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention can be used to provide a more efficient and less error-prone method of detecting variants in DNA, such as SNPs and indels. The invention also provides a method for performing inexpensive multiplex assays. The invention also provides methods for detection of DNA sequences altered after cleavage by a targetable endonuclease, such as the CRISPR Cas9 protein from the bacterium Streptococcus pyogenes.
Claims
exact text as granted — not AI-modified1 . A blocked-cleavable primer for rhPCR, the primer comprising:
5′-A-B-Z-E-3′
wherein
A is optional and is a tail extension that is not complementary to a target;
B is a sequence domain that is complementary to a target;
Z comprises:
C, a discrimination domain, and
D, a cleavage domain that, when hybridized to the target, is cleavable by RNase H2; and
E is a blocking domain that prevents extension of the primer.
2 . The primer of claim 1 , wherein the discrimination domain C is located 5′ of the cleavage domain D.
3 . The primer of claim 1 , wherein the discrimination domain C is located 3′ of the cleavage domain D.
4 . The primer of claim 1 , wherein the discrimination domain C overlaps with the cleavage domain D.
5 . The primer of claim 1 , wherein C comprises 1-3 RNA bases.
6 . The primer of claim 1 , wherein C comprises 1 RNA base.
7 . The primer of claim 6 , wherein the discrimination domain C consists of the 1 RNA base.
8 . The primer of claim 1 , wherein the cleavage domain comprises one or more of the following moieties: a DNA residue, an abasic residue, a modified nucleoside, or a modified phosphate internucleotide linkage.
9 . The primer of claim 8 , wherein a sequence flanking the cleavage site contains one or more internucleoside linkages resistant to nuclease cleavage.
10 . The primer of claim 9 , wherein the nuclease resistant linkage is a phosphorothioate.
11 . The primer of claim 5 , wherein the 3′ oxygen atom of at least one of the RNA residues is substituted with an amino group, thiol group, or a methylene group.
12 . The primer of claim 1 , wherein the blocking group is attached to the 3′-terminal nucleotide of the primer.
13 . The primer of claim 1 , wherein A comprises a region that is identical to a universal forward primer and optionally a probe binding domain.
14 - 54 . (canceled)Join the waitlist — get patent alerts
Track US2019218611A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.